#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Plasma cell myeloma recurrent Adenomatous polyposis coli Osteomyelitis Carcinoid syndrome Adenocarcinoma pancreas Antiphospholipid syndrome Pancreatic carcinoma Epstein-Barr virus infection Round cell liposarcoma Diffuse large B-cell lymphoma refractory Cystic fibrosis lung Rosai-Dorfman syndrome Chronic lymphocytic leukaemia refractory Post transplant lymphoproliferative disorder Anaemia More trials…

    Learn about Rare Diseases

    Vascular malformation – Trials in Disease Acquired haemophilia – Basic Information Skin angiosarcoma – Trials in Disease Sarcoidosis – Life with Disease Glycogen storage disease type I Von Willebrand’s disease – Trials in Disease Castleman’s disease – Treatment Haemophilia Rhabdomyosarcoma recurrent – Treatment KBG syndrome – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Methyl Aminolevulinate E2814 Fluoxetine Hydrochloride Cetirizine Dihydrochloride Stiripentol Vibostolimab BRENSOCATIB Izaflortaucipir (18F) Zipalertinib Naloxone Hydrochloride Radiprodil Amisulpride Deupirfenidone Irbesartan Noradrenaline Tartrate N-Tec Satralizumab Levamlodipine Succinate Topotecan Hydrochloride Bleomycin Sulfate More therapies…

    Learn about Your Condition

    Malignant mast cell neoplasm Pharyngeal cancer stage III Tooth loss H1N1 influenza Haemorrhage intracranial Spinal cord injury Leber's congenital amaurosis Post-traumatic headache Lymphocyte adoptive therapy Fallopian tube cancer Plasma cell myeloma recurrent Labour pain Ischaemic skin ulcer Gastrooesophageal cancer Indolent systemic mastocytosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • A study evaluating the efficacy and safety of secukinumab compared to a drug combination in patients with severe Takayasu arteritis.

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Adalimumab
    • Infliximab
    • Secukinumab
    France

  • Study of budesonide suppositories to treat acute radiation proctitis in men with prostate cancer

    Recruiting

    2 1 1
    Investigated Drugs:
    • Budesonide
    Austria Germany

  • A study to evaluate the use of FAPI-46 (68Ga) imaging to detect peritoneal cancer spread in patients with colorectal, gastric, ovarian, or pancreatic cancer

    Recruiting

    4 1 1
    Investigated Diseases:
    • Gastric cancer
    • Pancreatic carcinoma
    • Colorectal cancer
    Investigated Drugs:
    • (S)-2,2′,2”-(10-(2-(4-(3-((4-(2-(2-Cyano-4,4-Difluoropyrrolidin-1-Yl)-2-Oxoethylcarbamoyl)-Quinolin-6-Yl)(Methyl)Amino)-Propyl)Piperazin-1-Yl)-2-Oxoethyl)-68Ga-[1,4,7,10]-Tetraazacyclododecane-1,4,7-Triyl)Triacetate
    The Netherlands Sweden

  • A study of Enzomenib in adult patients with relapsed or refractory acute leukemia, including those with MLL rearrangement or NPM1 mutation.

    Recruiting

    2 1 1
    Investigated Diseases:
    • Acute leukaemia
    Belgium France Italy Spain

  • A study to evaluate the long-term safety and effectiveness of mRNA-3927 in patients with Propionic Acidemia

    Recruiting

    1 1 1
    Investigated Diseases:
    • Propionic acidaemia
    Investigated Drugs:
    • Modified Messenger Ribonucleic Acid Encoding Human Propionyl-Coenzyme A Carboxylase Alpha And Beta Subunits Encapsulated Into Lipid Nanoparticles
    France The Netherlands Spain

  • A safety study of romosozumab in children and adolescents with osteogenesis imperfecta

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Osteogenesis imperfecta
    Investigated Drugs:
    • Romosozumab
    Austria Belgium Germany Hungary Italy Slovakia +1
Previous Page
1 … 58 59 60 61 62 … 1,646
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!